SCHEMBL29875889

SCHEMBL29875889

Oc1cccc2occc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.45
FTO Q9C0B1 2/20 0.45
MAOB P27338 1/20 0.45
HPGD P15428 4/20 0.41
HSD17B10 Q99714 3/20 0.41
ALOX15 P16050 2/20 0.41
RECQL P46063 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
MAPT P10636 2/20 0.41
CYP1A2 P05177 1/20 0.41
APP P05067 1/20 0.41
THRB P10828 1/20 0.41
TSHR P16473 1/20 0.41
CASP1 P29466 1/20 0.41
SNCA P37840 1/20 0.41
KCNA3 P22001 1/20 0.40
ALDH1A1 P00352 3/20 0.38
EGFR P00533 2/20 0.38
CA1 P00915 2/20 0.38
CYP3A4 P08684 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL275378 1.00 MAOA (0.45) MAOAFTOMAOBHPGDHSD17B10
Formaldehyde SCHEMBL28073057 0.94 MAOA (0.45) MAOAFTOMAOBHPGDHSD17B10
Toluene SCHEMBL28185032 0.87 MAOA (0.40) MAOAFTOMAOBHPGDHSD17B10
1-Naphthol SCHEMBL17580890 0.76 CYP1A2 (0.63) MAOAFTOMAOBHPGDHSD17B10
1-Naphthol SCHEMBL29215642 0.76 CYP1A2 (0.63) MAOAFTOMAOBHPGDHSD17B10
SCHEMBL13947728 0.73 MAOA (0.46) MAOAFTOMAOBHPGDHSD17B10
SCHEMBL19354174 0.73 MAOA (0.42) MAOAFTOMAOBHPGDHSD17B10
SCHEMBL824913 0.71 CYP3A4 (0.48) MAOAFTOMAOBHPGDHSD17B10
SCHEMBL289214 0.71 MAOA (0.45) MAOAFTOMAOBHPGDHSD17B10
SCHEMBL275377 0.71 MAOA (0.50) MAOAFTOMAOBHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642784-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC Therapeutics, Inc. (US) 2025-11-05 EP claimed
WO-2024145623-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC THERAPEUTICS, INC. (US) 2024-07-04 WO claimed
WO-2022213932-A1 PYRROLOPYRIMIDINONE COMPOUND AND APPLICATION THEREOF 广州必贝特医药股份有限公司 2022-10-13 WO disclosed